Conference on genomic stability and cancer treatment
Official title: 2024 SoCal Genome Stability Symposium
Funded at Scripps Research Institute, the · NIH-11075025 · Data updated 2026-11-12
The 2024 SoCal Genome Stability Symposium is a friendly one-day event in La Jolla, California, where scientists, especially students and early-career researchers, will share their latest discoveries about how DNA problems can lead to cancer and how we can fix them, all while helping each other grow in their careers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | December 13, 2024 |
| Project end | December 12, 2025 |
| Funding year | 2025 |
| Award (this year) | $5,000 |
| NIH project number | 1R13CA298718-01 |
| Project ID | NIH-11075025 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation would be graduate students and postdoctoral fellows in the field of cancer research.
✕Less likely to help
Patients who are not involved in academic research or do not have a background in cancer biology may not receive direct benefits from this conference.
What this research studies
The 2024 SoCal Genome Stability Symposium is a one-day conference held at The Scripps Research Institute in La Jolla, California. It will focus on important topics such as genomic instability, DNA damage signaling, and mechanisms of DNA repair, all of which are crucial for understanding cancer etiology and treatment. The conference aims to foster the exchange of new research findings and innovative ideas, particularly by providing a platform for graduate students and postdoctoral fellows to present their unpublished research. This event is designed to enhance the career development of young scientists through networking and mentoring opportunities, and it is free for all participants from Southern California.
Why it matters
Potential benefit: If successful, this research could lead to new insights and advancements in cancer treatment strategies.
How similar studies have gone: Similar conferences have successfully facilitated knowledge exchange and collaboration in the field, indicating a positive precedent for this approach.
Where this research is happening
-
Scripps Research Institute, the
La Jolla, United States Active
Researchers
- Principal investigator: Wu, Xiaohua — Scripps Research Institute, the
- Study coordinator: Wu, Xiaohua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.